A citation-based method for searching scientific literature

M J Silverstein, K A Skinner, T J Lomis. World J Surg 2001
Times Cited: 160







List of co-cited articles
581 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
18

Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution.
Giuseppe Viale, Stefano Zurrida, Eugenio Maiorano, Giovanni Mazzarol, Giancarlo Pruneri, Giovanni Paganelli, Patrick Maisonneuve, Umberto Veronesi. Cancer 2005
147
16

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
15


Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
14


Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.
B Fisher, M Bauer, D L Wickerham, C K Redmond, E R Fisher, A B Cruz, R Foster, B Gardner, H Lerner, R Margolese. Cancer 1983
822
12

A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale, Alberto Luini, Stefano Zurrida, Viviana Galimberti, Mattia Intra, Paolo Veronesi, Chris Robertson, Patrick Maisonneuve,[...]. N Engl J Med 2003
12

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
11


Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
D E Rivadeneira, R M Simmons, P J Christos, K Hanna, J M Daly, M P Osborne. J Am Coll Surg 2000
115
11

Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses.
P H Gann, S A Colilla, S M Gapstur, D J Winchester, D P Winchester. Cancer 1999
79
12

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
10

Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review.
Soledad Alvarez, Enrique Añorbe, Pilar Alcorta, Fernando López, Ignacio Alonso, Julia Cortés. AJR Am J Roentgenol 2006
295
10

Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
José Luiz B Bevilacqua, Michael W Kattan, Jane V Fey, Hiram S Cody, Patrick I Borgen, Kimberly J Van Zee. J Clin Oncol 2007
187
10

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, Patrick W Whitworth, Douglas S Reintgen, Peter W Blumencranz, A Marilyn Leitch, Sukumal Saha, Kelly K Hunt, Armando E Giuliano. J Clin Oncol 2007
532
10

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
251
9

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
205
9

Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.
I A Olivotto, J S Jackson, D Mates, S Andersen, W Davidson, C J Bryce, J Ragaz. Cancer 1998
102
9

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Joseph P Costantino, Takamaru Ashikaga, Donald L Weaver, Eleftherios P Mamounas, Lynne M Jalovec,[...]. Lancet Oncol 2010
965
9

A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Kimberly J Van Zee, Donna-Marie E Manasseh, Jose L B Bevilacqua, Susan K Boolbol, Jane V Fey, Lee K Tan, Patrick I Borgen, Hiram S Cody, Michael W Kattan. Ann Surg Oncol 2003
569
8

Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
D A Fein, B L Fowble, A L Hanlon, M A Hooks, J P Hoffman, E R Sigurdson, L A Jardines, B L Eisenberg. J Surg Oncol 1997
77
10

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Armando E Giuliano, Linda McCall, Peter Beitsch, Pat W Whitworth, Peter Blumencranz, A Marilyn Leitch, Sukamal Saha, Kelly K Hunt, Monica Morrow, Karla Ballman. Ann Surg 2010
788
8


Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.
Simon J Crabb, Maggie C U Cheang, Samuel Leung, Taina Immonen, Torsten O Nielsen, David D Huntsman, Chris D Bajdik, Stephen K Chia. Clin Breast Cancer 2008
115
8

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
N Klauber-DeMore, L K Tan, L Liberman, S Kaptain, J Fey, P Borgen, A Heerdt, L Montgomery, M Paglia, J A Petrek,[...]. Ann Surg Oncol 2000
229
7

Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Mattia Intra, Paolo Veronesi, Giovanni Mazzarol, Viviana Galimberti, Alberto Luini, Virgilio Sacchini, Giuseppe Trifirò, Oreste Gentilini, Giancarlo Pruneri, Paola Naninato,[...]. Arch Surg 2003
120
7

Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ.
Tricia A Kelly, Julian A Kim, Rebecca Patrick, Sharon Grundfest, Joseph P Crowe. Am J Surg 2003
56
12

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
403
7

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
166
7

Trends in the treatment of ductal carcinoma in situ of the breast.
Nancy N Baxter, Beth A Virnig, Sara B Durham, Todd M Tuttle. J Natl Cancer Inst 2004
255
7

Sentinel lymph node biopsy for localised ductal carcinoma in situ?
P Veronesi, M Intra, A R Vento, P Naninato, P Caldarella, G Paganelli, G Viale. Breast 2005
60
11

Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
V Ozmen, H Karanlik, N Cabioglu, A Igci, M Kecer, O Asoglu, S Tuzlali, A Mudun. Breast Cancer Res Treat 2006
57
12

Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study.
Deepak G Bedi, Rajesh Krishnamurthy, Savitri Krishnamurthy, Beth S Edeiken, Huong Le-Petross, Bruno D Fornage, Roland L Bassett, Kelly K Hunt. AJR Am J Roentgenol 2008
150
7

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.
Fabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, Marc A Bollet, Jean-Yves Pierga, Severine Alran, Remy J Salmon, Virginie Fourchotte, Anne Vincent-Salomon, Xavier Sastre-Garau,[...]. PLoS One 2011
72
9

The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Jonathan F Lara, Steven M Young, Rowena E Velilla, Elissa J Santoro, Sandra F Templeton. Cancer 2003
94
6

Sentinel node biopsy in ductal carcinoma in situ patients.
S Pendas, E Dauway, R Giuliano, N Ku, C E Cox, D S Reintgen. Ann Surg Oncol 2000
139
6

An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Emmanuel Barranger, Charles Coutant, Antoine Flahault, Yann Delpech, Emile Darai, Serge Uzan. Breast Cancer Res Treat 2005
191
6

Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Tomoaki Harada, Nobuhiko Tanigawa, Mitsuru Matsuki, Takehiro Nohara, Isamu Narabayashi. Eur J Radiol 2007
54
11

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.
T Nemoto, J Vana, R N Bedwani, H W Baker, F H McGregor, G P Murphy. Cancer 1980
569
6

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
U Veronesi, G Paganelli, V Galimberti, G Viale, S Zurrida, M Bedoni, A Costa, C de Cicco, J G Geraghty, A Luini,[...]. Lancet 1997
6

Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.
Rosa F Hwang, Savitri Krishnamurthy, Kelly K Hunt, Nadeem Mirza, Frederick C Ames, Barry Feig, Henry M Kuerer, S Eva Singletary, Gildy Babiera, Funda Meric,[...]. Ann Surg Oncol 2003
214
6

A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
A Pal, E Provenzano, S W Duffy, S E Pinder, A D Purushotham. Br J Surg 2008
165
6

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
85
7


Predicting axillary lymph node metastases in patients with T1 infiltrating ductal carcinoma of the breast.
S P Harden, A J Neal, N Al-Nasiri, S Ashley, G Querci della Rovere. Breast 2001
20
30

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Takamaru Ashikaga, Donald L Weaver, Barbara J Miller, Lynne M Jalovec, Thomas G Frazier,[...]. Lancet Oncol 2007
665
6

Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.
Emi Yoshihara, Ann Smeets, Annouchka Laenen, Anneleen Reynders, Julie Soens, Chantal Van Ongeval, Philippe Moerman, Robert Paridaens, Hans Wildiers, Patrick Neven,[...]. Breast 2013
59
10

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Ben Van Calster, Isabelle Vanden Bempt, Maria Drijkoningen, Nathalie Pochet, Jiqiu Cheng, Sabine Van Huffel, Wouter Hendrickx, Julie Decock, Huei-Jean Huang, Karin Leunen,[...]. Breast Cancer Res Treat 2009
66
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.